Stockreport

IGM Biosciences: Imvotamab Data 2nd Half Of 2024 With Other Inflection Points [Seeking Alpha]

IGM Biosciences, Inc.  (IGMS) 
Last igm biosciences, inc. earnings: 3/26 04:05 pm Check Earnings Report
PDF The global lupus market is projected to grow to $6.78 billion by 2032 and the global Rheumatoid Arthritis drugs market size is projected to reach $38.61 billion by 2032 [Read more]